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Introduction
Juvenile Idiopathic Arthritis (JIA) is the most chronic
musculoskeletal disease of pediatric population. Its inci-
dence and prevalence vary considerably throught the
world. The Spanish Society of Rheumatology has esti-
mated a incidence and prevalence of 8-22/100.000 and
0.7-40/100.000 respectively.
Objectives
Estimate the incidence and prevalence of juvenile idio-
pathic arthritis (JIA) in a paediatric tertiary care centre
of Spain.
Methods
A 15-years (1997-2012), prospective, population-based
study was then carried out to determine the incidence
of JIA. Prospective and retrospective data retrieval was
performed to calculate prevalence. The International
League of Associations for Rheumatology (ILAR,
Edmonton revision) classification criteria were applied.
Data were compared by Chi-square, student t or wil-
coxon test. Significance was set at 5%. Statistical analysis
was performed with SPSS version 15.0 software.
Results
We identified 132 cases of JIA JIA according to ILAR
criteria: 81 girls (61.4%) and 51 boys (38.6%). Over the
study period, 20 new cases of JIA were diagnosed in
Zaragoza. The mean annual incidence was 14.8/100000
children aged less than 16 years. In Aragón 23 new
cases cases of JIA were diagnosed so the mean annual
incidence was 14.8/100000 and prevalence was 34.64/
100.000 children aged less than 16 years.
The mean age was 7.54 years (95 % CI: 6.82-8.25 ) .
The most frequent form of onset was persistent oligoar-
ticular arthritis, followed by enthesitis-related arthritis,
psoriatic arthritis, rheumatoid factor negative polyarticu-
lar arthritis, undifferentiaded arthritis, systemic disease
and rheumatoid factor positive polyarticular arthritis.
In boys the most frequent category was been arthritis -
enthesitis (n = 28, 54.9 %) and in girls was oligoarticular
JIA (n = 55, 67.9 %). The average age at which the arthri-
tis was diagnosed was significantly earlier in the group of
patients who of oligoarticular disease (6.4 years) than
patients who polyarticular seropositive disease
(10.74 years).
Conclusion
Incidence and prevalence rates are similar than those
reported for several countries of Europe. To avoid
underestimation of incidence and prevalence, epidemio-
logical studies of JIA should be population-based rather
than referral center-based. Further descriptive studies of
JCA in different well-defined geographic areas are
important to make valid comparisons. Such comparisons
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